A detailed history of Wormser Freres Gestion transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Wormser Freres Gestion holds 92,120 shares of EW stock, worth $6.75 Million. This represents 4.1% of its overall portfolio holdings.

Number of Shares
92,120
Previous 92,223 0.11%
Holding current value
$6.75 Million
Previous $6.1 Billion 12.91%
% of portfolio
4.1%
Previous 3.73%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 20, 2025

SELL
$64.54 - $75.92 $6,647 - $7,819
-103 Reduced 0.11%
92,120 $6.89 Billion
Q3 2024

Feb 20, 2025

BUY
$59.7 - $93.78 $104,534 - $164,208
1,751 Added 1.94%
92,223 $6.1 Billion
Q2 2024

Feb 20, 2025

SELL
$84.3 - $94.31 $82,614 - $92,423
-980 Reduced 1.07%
90,472 $8.63 Billion
Q1 2024

Feb 20, 2025

BUY
$72.54 - $95.56 $2.91 Million - $3.83 Million
40,073 Added 77.99%
91,452 $8.9 Billion
Q4 2023

Feb 20, 2025

BUY
$61.71 - $77.76 $3.17 Million - $4 Million
51,379 New
51,379 $3.95 Billion

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $45.3B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Wormser Freres Gestion Portfolio

Follow Wormser Freres Gestion and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wormser Freres Gestion, based on Form 13F filings with the SEC.

News

Stay updated on Wormser Freres Gestion with notifications on news.